Literature DB >> 22174197

Performance of risk indices for identifying low bone mineral density and osteoporosis in Mexican Mestizo women with rheumatoid arthritis.

Laura Gonzalez-Lopez1, Jorge I Gamez-Nava, Anahi Vega-Lopez, N Alejandra Rodriguez-Jimenez, Norma Gonzalez-Montoya, Erika Aguilar-Chavez, M Fabiola Alcaraz-Lopez, Alberto D Rocha-Muñoz, Natasha Castro-Lizano, Jaime Morales-Romero, Mario Salazar-Paramo, Maria E Suarez-Almazor.   

Abstract

OBJECTIVE: We evaluated the utility of 6 generic and 2 specific risk indices for identifying low bone mineral density (BMD) or osteoporosis in women with rheumatoid arthritis (RA); and their correlation with 10-year probability of fractures as assessed with the World Health Organization fracture risk assessment (FRAX) tool.
METHODS: Mexican Mestizo women with RA were evaluated in this cross-sectional study using 6 generic indices [Simple Calculated Osteoporosis Risk Estimation (SCORE); Osteoporosis Risk Assessment Instrument (ORAI); Osteoporosis Self-Assessment Tool; Age, Body Size, No Estrogen; Osteoporosis Index of Risk (OSIRIS); and Guidelines of the US National Osteoporosis Foundation], 2 specific indices (Amsterdam and modified Amsterdam), and FRAX. BMD results on dual-energy x-ray absorptiometry (DEXA) at the lumbar spine and femoral neck were considered the "gold standard." Sensitivity, specificity, and predictive values (PV) of the indices and their correlations with FRAX results were estimated.
RESULTS: Among 191 patients, 46 had osteoporosis (24.1%) and 119 had low BMD (62.3%). For predicting osteoporosis, SCORE showed the highest sensitivity (96%), whereas OSIRIS (87%) and ORAI (82%) showed the highest specificities. OSIRIS also had the greatest positive PV (92%). The specific indices had low sensitivity and low specificity (Amsterdam, 50% and 79%, respectively; modified Amsterdam, 56% and 70%). All the indices had a low but significant correlation with FRAX.
CONCLUSION: These findings support the use of some generic indices to identify patients with RA who should undergo DEXA testing. Currently available specific indices did not perform satisfactorily. New specific risk indices for osteoporosis in RA should be developed to increase sensitivity and specificity for predicting osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22174197     DOI: 10.3899/jrheum.110467

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

Review 1.  Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density.

Authors:  S Nayak; D L Edwards; A A Saleh; S L Greenspan
Journal:  Osteoporos Int       Date:  2015-02-03       Impact factor: 4.507

2.  Prevalence and associated factors of osteoporosis in female patients with rheumatoid arthritis.

Authors:  Maryam Mobini; Zahra Kashi; Asieh Ghobadifar
Journal:  Caspian J Intern Med       Date:  2012

3.  The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis.

Authors:  Joo-Hyun Lee; Yoon-Kyoung Sung; Chan-Bum Choi; Soo-Kyung Cho; So-Young Bang; Jung-Yoon Choe; Seung-Jae Hong; Jae-Bum Jun; Tae-Hwan Kim; Jisoo Lee; Hye-Soon Lee; Dae-Hyun Yoo; Bo Young Yoon; Sang-Cheol Bae
Journal:  BMC Musculoskelet Disord       Date:  2016-02-24       Impact factor: 2.362

4.  Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study.

Authors:  C A Nava-Valdivia; J M Ponce-Guarneros; A M Saldaña-Cruz; E G Corona-Sanchez; M Ramirez-Villafaña; E E Perez-Guerrero; J D Murillo-Saich; B Contreras-Haro; M L Vazquez-Villegas; F Gonzalez-Ponce; D Bonilla-Lara; H Jacobo-Cuevas; J D Centeno-Valadez; G Echeverria-Gonzalez; S Cerpa-Cruz; M F Alcaraz-Lopez; E G Cardona-Muñoz; M Salazar-Paramo; L Gonzalez-Lopez; J I Gamez-Nava
Journal:  Biomed Res Int       Date:  2021-08-30       Impact factor: 3.411

5.  The prevalence of osteoporosis in rheumatoid arthritis patient: a systematic review and meta-analysis.

Authors:  Samaneh Moshayedi; Baharak Tasorian; Amir Almasi-Hashiani
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.